CN1061246C - Medicine for treating alimentary canal system disease - Google Patents
Medicine for treating alimentary canal system disease Download PDFInfo
- Publication number
- CN1061246C CN1061246C CN97104016A CN97104016A CN1061246C CN 1061246 C CN1061246 C CN 1061246C CN 97104016 A CN97104016 A CN 97104016A CN 97104016 A CN97104016 A CN 97104016A CN 1061246 C CN1061246 C CN 1061246C
- Authority
- CN
- China
- Prior art keywords
- medicine
- weight portion
- weight portions
- weight
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses stomachic medicine for treating alimentary canal system diseases, which is formed by preparing haws, raphanin, malt, lindera root, radix auckladiae, atractylodes, betel nut and pseudostellariae. The present invention can be used for treating diseases such as deficiency of a spleen and a stomach, abdominal swelling pain, anorexia, belch, vomit of sour fluid, sticky loose stools, yin deficiency constipation, chronic gastritis, superficial gastritis, duodenal ulcer, etc.
Description
The present invention is a kind of medicine for the treatment of digestive system disease, specifically be a kind of be the stomachic that feedstock production forms with Chinese medicine, belong to drug world.
Digestive system disease is a kind of common frequently-occurring disease, disease such as symptom mainly shows as distension and fullness of the chest and abdomen, gastralgia, pantothenic acid, heating installation, inappetence, become thin.Western medicine diagnose mostly is gastritis, Peptic Ulcers etc.For the medicine of digestive system disease, it is a lot of to sell kind at present on the market, for example, XIANGSHA YANGWEI WAN is arranged, SHUGAN HEWEI WAN, and lenitive pill, SHENLING BAISHU SAN etc., these medicines all have to a certain degree therapeutical effect to digestive system disease.Because the spleen and stomach illness is based on void, therefore, these known drug are many based on tonify deficiency, for the existing insufficiency of the spleen patient that dyspepsia is arranged again, are unsuitable for taking.Insufficiency of the spleen should the benefit, dyspepsia should disappear, and the two has the real obstinate disease that belongs to concurrently.Therefore, be necessary very much to develop a kind of can the insufficiency of the spleen medicine that can eliminate dyspepsia again of tonification, to satisfy the demand of clinical patient.
The object of the invention provides the stomachic of the empty eliminating indigested food of a kind of spleen reinforcing.
Medicine of the present invention is that the guiding theory according to traditional Chinese medical science ancient books " Treatise on the spleen and stomach " develops.Helping digestion with spleen reinforcing is the rule of treatment, forms prescription, weakness of the spleen and stomach, retention of food and drink, mechanism of qi is obstructed, should first strengthening the spleen and stomach, back circulation of qi promoting stagnates, so just with the Rhizoma Atractylodis Macrocephalae, Radix Pseudostellariae strengthening the spleen and stomach, fill blood, except that damp-heat in the spleen and stomach and diversion is descending; Retention of food and drink, mechanism of qi is impaired, and stomach accommodates and falls, the stomach function regulating that should help digestion earlier, it is main clearing away the dampness and heat, so remove bloated with Fructus Crataegi, Semen Raphani, Fructus Hordei Germinatus dyspepsia and intestinal stasis relieving, warming middle-JIAO; Distension and fullness of the chest and abdomen is answered warming spleen and stomach for dispelling cold, promoting the circulation of QI to relieve pain, so strengthen the merit of promoting the circulation of QI to relieve pain with the Radix Linderae, the Radix Aucklandiae, the secretion of facilitating digestion liquid guarantees that gastrointestinal normally moves.All medicines share the effect of playing strengthening the spleen to promote digestion altogether.
Therefore, medicine of the present invention is to be the medicament that active constituent is prepared from following pharmaceutical composition:
Fructus Crataegi 20-30 weight portion
Semen Raphani 20-30 weight portion
Fructus Hordei Germinatus 10-20 weight portion
Radix Linderae 10-20 weight portion
Radix Aucklandiae 10-20 weight portion
Rhizoma Atractylodis Macrocephalae 5-10 weight portion
Semen Arecae 5-10 weight portion
Radix Pseudostellariae 5-10 weight portion
Its preferred weight ratio of pharmaceutical composition of the present invention is:
Fructus Crataegi 25 weight portions
Semen Raphani 25 weight portions
Fructus Hordei Germinatus 15 weight portions
The Radix Linderae 15 weight portions
The Radix Aucklandiae 15 weight portions
The Rhizoma Atractylodis Macrocephalae 7 weight portions
Semen Arecae 7 weight portions
Radix Pseudostellariae 7 weight portions
Aforementioned pharmaceutical compositions of the present invention can be prepared into any pharmaceutical dosage form that is suitable for clinical use according to conventional formulation technology, for example, and pill, powder, tablet, capsule, oral liquid, unguentum, suspensoid etc.
Before aforementioned pharmaceutical compositions of the present invention was prepared into medicament, preferred elder generation concocted each component, pulverize, and concocting method is concocted according to the concocted specification of state-promulgated pharmacopoeia.Wherein Fructus Crataegi, Semen Raphani, Fructus Hordei Germinatus, Semen Arecae are the product of fruit, and hard varying degree should be carried out drying respectively with it.Because the Semen Raphani oil content is more, Fructus Hordei Germinatus body lightweight is crisp and be easy to pulverize, and Semen Arecae body weight matter heavily fortified point is unsuitable for pulverizing, and the Radix Linderae, Radix Aucklandiae body is light and be rich in more fiber properties.For this reason, also should pulverize respectively for these medicines.
After said medicine is pulverized respectively, with No. 6 dusting covers medicine is sieved, remaining fine powder is pulverized again, until no granular till.
Medicated powder after the above-mentioned pulverizing, mix homogeneously, after the sterilization, packing promptly makes powder.
Medicine of the present invention is preferably made tablet.
The preparation method of tablet is:
Composition and usage ratio thereof according to aforementioned pharmaceutical compositions are chosen medicine respectively, carry out drying respectively, pulverize, and cross No. 6 dusting covers, and remaining fine powder is pulverized again, until no granular till.Then with each medicated powder mix homogeneously, pelletize, granulate is gone into the tablet machine tabletting, promptly.
Medicine of the present invention is particularly suitable for existingly insufficiency of the spleenly having the patient of dyspepsia to take again; effect with promoting digestion and removing stagnation, spleen invigorating relieving distension, promoting the circulation of QI to relieve pain, dampness diuretic, warming kidney for dispelling cold, QI invigorating strengthening the spleen, YIN nourishing tonifying the lung, promoting the production of body fluid to quench thirst; can strengthen enzyme secretion in the stomach; the facilitating digestion function; and can strengthen myocardial contraction, and can also blood sugar lowering, the effect of antipathogen growth is arranged; can suppress escherichia coli, anti-inflammatory and antalgic, detoxifcation, have the liver protecting and antineoplastic action.Can be used for treating diseases such as weakness of the spleen and stomach, abdominal distention, anorexia, belch acid regurgitation, diarrhea with loose stool, treaitng Yin-deficiency constipation, chronic gastritis, superficial gastritis and duodenal ulcer.
Embodiment 1
Fructus Crataegi 25 grams
Semen Raphani 25 grams
Fructus Hordei Germinatus 15 grams
The Radix Linderae 15 grams
The Radix Aucklandiae 15 grams
The Rhizoma Atractylodis Macrocephalae 7 grams
Semen Arecae 7 grams
Radix Pseudostellariae 7 grams
Choose medicine respectively according to above-mentioned prescription, carry out drying respectively, pulverize, cross No. 6 dusting covers, remaining fine powder is pulverized again, until no granular till.Then with each medicated powder mix homogeneously, pelletize, granulate is gone into the tablet machine tabletting, makes tablet.
Embodiment 2
Fructus Crataegi 20 grams
Semen Raphani 20 grams
Fructus Hordei Germinatus 25 grams
The Radix Linderae 10 grams
The Radix Aucklandiae 15 grams
The Rhizoma Atractylodis Macrocephalae 10 grams
Semen Arecae 7 grams
Radix Pseudostellariae 10 grams
After said medicine is pulverized respectively, with No. 6 dusting covers medicine is sieved, remaining fine powder is pulverized again, until no granular till.With the medicated powder after pulverizing, mix homogeneously, after the sterilization, packing promptly makes powder.
Claims (4)
1, a kind of medicine for the treatment of digestive system disease, the active ingredient that it is characterized in that it is formed by the feedstock production of following consumption proportion:
Fructus Crataegi 20-30 weight portion
Semen Raphani 20-30 weight portion
Fructus Hordei Germinatus 10-20 weight portion
Radix Linderae 10-20 weight portion
Radix Aucklandiae 10-20 weight portion
Rhizoma Atractylodis Macrocephalae 5-10 weight portion
Semen Arecae 5-10 weight portion
Radix Pseudostellariae 5-10 weight portion.
2, according to the medicine of claim 1, the active ingredient that it is characterized in that it is formed by the feedstock production of following consumption proportion:
Fructus Crataegi 25 weight portions
Semen Raphani 25 weight portions
Fructus Hordei Germinatus 15 weight portions
The Radix Linderae 15 weight portions
The Radix Aucklandiae 15 weight portions
The Rhizoma Atractylodis Macrocephalae 7 weight portions
Semen Arecae 7 weight portions
Radix Pseudostellariae 7 weight portions.
3, claim 1 or 2 described medicines is characterized in that this medicine is a tablet.
4, claim 1 or 2 described medicines is characterized in that this medicine is a powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97104016A CN1061246C (en) | 1997-04-16 | 1997-04-16 | Medicine for treating alimentary canal system disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97104016A CN1061246C (en) | 1997-04-16 | 1997-04-16 | Medicine for treating alimentary canal system disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1196246A CN1196246A (en) | 1998-10-21 |
| CN1061246C true CN1061246C (en) | 2001-01-31 |
Family
ID=5167060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97104016A Expired - Fee Related CN1061246C (en) | 1997-04-16 | 1997-04-16 | Medicine for treating alimentary canal system disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1061246C (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1093915A (en) * | 1993-07-09 | 1994-10-26 | 四平市益民制药厂 | Qipi oral liquid and preparation method thereof |
| CN1106288A (en) * | 1994-02-04 | 1995-08-09 | 湖南省国药开发总公司 | Oral mushroom liquor |
-
1997
- 1997-04-16 CN CN97104016A patent/CN1061246C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1093915A (en) * | 1993-07-09 | 1994-10-26 | 四平市益民制药厂 | Qipi oral liquid and preparation method thereof |
| CN1106288A (en) * | 1994-02-04 | 1995-08-09 | 湖南省国药开发总公司 | Oral mushroom liquor |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1196246A (en) | 1998-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066445A (en) | Chinese medicine prepn for curing gastropathy radically | |
| CN1943773B (en) | A Chinese traditional medicinal composition and its preparation methods | |
| CN101041050A (en) | Chinese traditional medicine compound took orally for treating chronic gastritis | |
| CN104547775A (en) | Traditional Chinese medicine for treating syndrome of dampness-heat in middle jiao | |
| CN1895573A (en) | Pharmaceutical composition for treating oral ulcer and preparation method and application thereof | |
| CN101780246B (en) | Traditional Chinese medicine composition with function of promoting digestion and preparation method thereof | |
| CN1850237A (en) | Medicine for treating chronic superficial gastritis and peptic ulcer diseases | |
| CN1171952A (en) | Traditional Chinese medicine preparation for eradicating Helicobacter phlori | |
| CN1899570A (en) | Medicine for treating digestive system diseases | |
| CN1168475C (en) | Chinese herbal medicine composition for treating pyloric spirobacterium infected gastropathy and its production process | |
| CN101036758A (en) | Chinese traditional medicine composition took orally for treating chronic superficial gastritis | |
| CN1208646A (en) | Medicine for treating gastrointestinal ulcer and gastritis | |
| CN1267119C (en) | Medication for curing skin disease | |
| CN1061246C (en) | Medicine for treating alimentary canal system disease | |
| CN1114431C (en) | Medicine for treating atrophic gastritis and its preparing process | |
| CN1903347A (en) | Medicine composition for treating alimentary canal diseases, prepn. method and application thereof | |
| CN100342877C (en) | Medicine for promoting qi circulation, resolving food retention, benefiting stomach and stopping pain and preparation process thereof | |
| CN1272056C (en) | Pure Chinese medicine preparation for treatinog peptic ulcer and preparing method thereof | |
| CN101670046A (en) | Chinese medicinal composition for gastritis and esophagitis and preparation process thereof | |
| CN1453004A (en) | Cathartic medicine and its prepn | |
| CN106860646B (en) | Traditional Chinese medicine composition for treating gastroduodenal ulcer and preparation method thereof | |
| CN1287847C (en) | Chinese medicine for treating acute and chronic nephritis and uremia | |
| CN1183981A (en) | Chinese medicine for gastropathy related to pyloric spiri-bacillus | |
| CN1583032A (en) | Chinese medicine preparation for stomach diseases | |
| CN1106848C (en) | Development of yaokang capsule and its clinical application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |